Tag: Depolarizing agent

First introduced in 1948, Decamethonium was a pioneering neuromuscular blocking agent for surgical anesthesia. It is most commonly known by its former brand name, Syncurine, and the shorthand C10. The drug was pivotal in the evolution of muscle relaxants but was ultimately replaced by safer, more controllable alternatives.

In healthy patients, the administration of succinylcholine, a depolarizing neuromuscular blocker, typically causes a transient increase in serum potassium of about 0.5 mEq/L [1.3.1, 1.9.2]. Understanding **what electrolyte abnormality is associated with succinylcholine** is critical for preventing life-threatening complications in at-risk patients.

Succinylcholine, a depolarizing neuromuscular blocker, has a rapid onset of action within 30 to 60 seconds after intravenous administration. This potent medication is used to induce short-term muscle paralysis for medical procedures, and understanding what does succinylcholine do is crucial for its safe and effective application.